Analysis

Optimi Health Corp. (OPTI) Stock Analysis

Optimi Health Corp. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to OPTI.

websiteOPTI/analysis/OPTI

Optimi Health Corp.

Optimi Health Corp. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to OPTI.

Stock profile

Ticker

OPTI

Asset type

Stock

Market cap

$28.3M

Sector

Process Industries

Industry

Agricultural Commodities/Milling

Currency

CAD

Ticker listings

Optimi Health Corp. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • OPTH
  • OPTI primary listing
  • 8BN
  • A2QQEL
  • 8BN0
  • A411WC

Latest Optimi Health Corp. news

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research

Two naturally derived finished drug products, at 1mg and 2mg, give research organizations the consistent, validated doses required for controlled studies New microdose formats e...

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial

The shipment of naturally derived psilocybin, comprising both biomass and 5mg capsules, supports a planned Phase 2 clinical trial in the United Kingdom and was completed under e...

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development

via IBN – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug pr...

Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia

via IBN – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug pr...

Optimi Health (OPTH) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update

LOS ANGELES, CA - May 29, 2026 (NEWMEDIAWIRE) - Optimi Health (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN), a commercial-stage psychedelic pharmaceutical manufacturer, welcomed final r...

Research sections

Valuation

Review valuation context for Optimi Health Corp..

Future growth

Review future growth context for Optimi Health Corp..

Past performance

Review past performance context for Optimi Health Corp..

Financial health

Review financial health context for Optimi Health Corp..

Dividend

Review dividend context for Optimi Health Corp..

Management

Review management context for Optimi Health Corp..

Ownership

Review ownership context for Optimi Health Corp..

Other information

Review other information context for Optimi Health Corp..

Community

Review community context for Optimi Health Corp..